Alto Neuroscience, Stock Volatility

ANRO Stock   4.16  0.06  1.42%   
Alto Neuroscience, secures Sharpe Ratio (or Efficiency) of -0.0835, which signifies that the company had a -0.0835% return per unit of risk over the last 3 months. Alto Neuroscience, exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alto Neuroscience,'s Risk Adjusted Performance of (0.05), standard deviation of 9.82, and Mean Deviation of 4.66 to double-check the risk estimate we provide. Key indicators related to Alto Neuroscience,'s volatility include:
90 Days Market Risk
Chance Of Distress
90 Days Economic Sensitivity
Alto Neuroscience, Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Alto daily returns, and it is calculated using variance and standard deviation. We also use Alto's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Alto Neuroscience, volatility.
  

ESG Sustainability

While most ESG disclosures are voluntary, Alto Neuroscience,'s sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alto Neuroscience,'s managers and investors.
Environmental
Governance
Social
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Alto Neuroscience, can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Alto Neuroscience, at lower prices. For example, an investor can purchase Alto stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Alto Neuroscience,'s stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Alto Stock

  0.7VRCA Verrica PharmaceuticalsPairCorr

Moving against Alto Stock

  0.87ELDN Eledon PharmaceuticalsPairCorr
  0.76VRNA Verona Pharma PLCPairCorr
  0.74ETON Eton Pharmaceuticals Potential GrowthPairCorr
  0.62EWTX Edgewise TherapeuticsPairCorr
  0.42DSGN Design TherapeuticsPairCorr

Alto Neuroscience, Market Sensitivity And Downside Risk

Alto Neuroscience,'s beta coefficient measures the volatility of Alto stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Alto stock's returns against your selected market. In other words, Alto Neuroscience,'s beta of 3.92 provides an investor with an approximation of how much risk Alto Neuroscience, stock can potentially add to one of your existing portfolios. Alto Neuroscience, is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Alto Neuroscience,'s stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Alto Neuroscience,'s stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Alto Neuroscience, Demand Trend
Check current 90 days Alto Neuroscience, correlation with market (Dow Jones Industrial)

Alto Beta

    
  3.92  
Alto standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  9.95  
It is essential to understand the difference between upside risk (as represented by Alto Neuroscience,'s standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Alto Neuroscience,'s daily returns or price. Since the actual investment returns on holding a position in alto stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Alto Neuroscience,.

Alto Neuroscience, Stock Volatility Analysis

Volatility refers to the frequency at which Alto Neuroscience, stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Alto Neuroscience,'s price changes. Investors will then calculate the volatility of Alto Neuroscience,'s stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Alto Neuroscience,'s volatility:

Historical Volatility

This type of stock volatility measures Alto Neuroscience,'s fluctuations based on previous trends. It's commonly used to predict Alto Neuroscience,'s future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Alto Neuroscience,'s current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Alto Neuroscience,'s to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Alto Neuroscience, Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

Alto Neuroscience, Projected Return Density Against Market

Given the investment horizon of 90 days the stock has the beta coefficient of 3.9243 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Alto Neuroscience, will likely underperform.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Alto Neuroscience, or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Alto Neuroscience,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Alto stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alto Neuroscience, has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Predicted Return Density   
       Returns  
Alto Neuroscience,'s volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how alto stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Alto Neuroscience, Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Alto Neuroscience, Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of Alto Neuroscience, is -1197.35. The daily returns are distributed with a variance of 98.95 and standard deviation of 9.95. The mean deviation of Alto Neuroscience, is currently at 4.66. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α
Alpha over Dow Jones
-1.23
β
Beta against Dow Jones3.92
σ
Overall volatility
9.95
Ir
Information ratio -0.09

Alto Neuroscience, Stock Return Volatility

Alto Neuroscience, historical daily return volatility represents how much of Alto Neuroscience, stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The firm inherits 9.9472% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7454% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About Alto Neuroscience, Volatility

Volatility is a rate at which the price of Alto Neuroscience, or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Alto Neuroscience, may increase or decrease. In other words, similar to Alto's beta indicator, it measures the risk of Alto Neuroscience, and helps estimate the fluctuations that may happen in a short period of time. So if prices of Alto Neuroscience, fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for Next Year
Selling And Marketing Expenses428.9 K315.3 K
Market Cap500.8 M445.2 M
Alto Neuroscience,'s stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Alto Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Alto Neuroscience,'s price varies over time.

3 ways to utilize Alto Neuroscience,'s volatility to invest better

Higher Alto Neuroscience,'s stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Alto Neuroscience, stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Alto Neuroscience, stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Alto Neuroscience, investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Alto Neuroscience,'s stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Alto Neuroscience,'s stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Alto Neuroscience, Investment Opportunity

Alto Neuroscience, has a volatility of 9.95 and is 13.27 times more volatile than Dow Jones Industrial. 88 percent of all equities and portfolios are less risky than Alto Neuroscience,. You can use Alto Neuroscience, to protect your portfolios against small market fluctuations. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Alto Neuroscience, to be traded at 4.04 in 90 days.

Weak diversification

The correlation between Alto Neuroscience, and DJI is 0.3 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Alto Neuroscience, and DJI in the same portfolio, assuming nothing else is changed.

Alto Neuroscience, Additional Risk Indicators

The analysis of Alto Neuroscience,'s secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Alto Neuroscience,'s investment and either accepting that risk or mitigating it. Along with some common measures of Alto Neuroscience, stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Alto Neuroscience, Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Alto Neuroscience, as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Alto Neuroscience,'s systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Alto Neuroscience,'s unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Alto Neuroscience,.
When determining whether Alto Neuroscience, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alto Neuroscience,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alto Neuroscience, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alto Neuroscience, Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alto Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alto Neuroscience,. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.38)
Return On Assets
(0.32)
Return On Equity
(0.57)
The market value of Alto Neuroscience, is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience,'s market value can be influenced by many factors that don't directly affect Alto Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Alto Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.